Fan Wei, Yang Heping, Liu Ting, Wang Jiaohong, Li Tony W H, Mavila Nirmala, Tang Yuanyuan, Yang JinWon, Peng Hui, Tu Jian, Annamalai Alagappan, Noureddin Mazen, Krishnan Anuradha, Gores Gregory J, Martínez-Chantar Maria L, Mato José M, Lu Shelly C
Division of Digestive and Liver Diseases, Cedars-Sinai Medical Center, Los Angeles, CA.
Department of Geriatrics, Guangzhou First People's Hospital, Guangzhou, China.
Hepatology. 2017 Apr;65(4):1249-1266. doi: 10.1002/hep.28964. Epub 2017 Jan 31.
Prohibitin 1 (PHB1) is best known as a mitochondrial chaperone, and its role in cancer is conflicting. Mice lacking methionine adenosyltransferase α1 (MATα1) have lower PHB1 expression, and we reported that c-MYC interacts directly with both proteins. Furthermore, c-MYC and MATα1 exert opposing effects on liver cancer growth, prompting us to examine the interplay between PHB1, MATα1, and c-MYC and PHB1's role in liver tumorigenesis. We found that PHB1 is highly expressed in normal hepatocytes and bile duct epithelial cells and down-regulated in most human hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA). In HCC and CCA cells, PHB1 expression correlates inversely with growth. PHB1 and MAT1A positively regulate each other's expression, whereas PHB1 negatively regulates the expression of c-MYC, MAFG, and c-MAF. Both PHB1 and MATα1 heterodimerize with MAX, bind to the E-box element, and repress E-box promoter activity. PHB1 promoter contains a repressive E-box element and is occupied mainly by MAX, MNT, and MATα1 in nonmalignant cholangiocytes and noncancerous tissues that switched to c-MYC, c-MAF, and MAFG in cancer cells and human HCC/CCA. All 8-month-old liver-specific Phb1 knockout mice developed HCC, and one developed CCA. Five-month-old Phb1 heterozygotes, but not Phb1 flox mice, developed aberrant bile duct proliferation; and one developed CCA 3.5 months after left and median bile duct ligation. Phb1 heterozygotes had a more profound fall in the expression of glutathione synthetic enzymes and higher hepatic oxidative stress following left and median bile duct ligation.
We have identified that PHB1, down-regulated in most human HCC and CCA, heterodimerizes with MAX to repress the E-box and positively regulates MAT1A while suppressing c-MYC, MAFG, and c-MAF expression; in mice, reduced PHB1 expression predisposes to the development of cholestasis-induced CCA. (Hepatology 2017;65:1249-1266).
prohibitin 1(PHB1)作为一种线粒体伴侣蛋白最为人所知,其在癌症中的作用存在争议。缺乏甲硫氨酸腺苷转移酶α1(MATα1)的小鼠PHB1表达较低,我们报道c-MYC与这两种蛋白都直接相互作用。此外,c-MYC和MATα1对肝癌生长发挥相反作用,促使我们研究PHB1、MATα1和c-MYC之间的相互作用以及PHB1在肝脏肿瘤发生中的作用。我们发现PHB1在正常肝细胞和胆管上皮细胞中高表达,而在大多数人类肝细胞癌(HCC)和胆管癌(CCA)中表达下调。在HCC和CCA细胞中,PHB1表达与生长呈负相关。PHB1和MAT1A相互正向调节彼此的表达,而PHB1负向调节c-MYC、MAFG和c-MAF的表达。PHB1和MATα1都与MAX形成异二聚体,结合E-box元件,并抑制E-box启动子活性。PHB1启动子含有一个抑制性E-box元件,在非恶性胆管细胞和非癌组织中主要被MAX、MNT和MATα1占据,在癌细胞和人类HCC/CCA中则转变为c-MYC、c-MAF和MAFG。所有8月龄肝脏特异性Phb1基因敲除小鼠都发生了HCC,并有一只发生了CCA。5月龄Phb1杂合子小鼠(而非Phb1 flox小鼠)出现异常胆管增生;一只在左、中胆管结扎3.5个月后发生了CCA。左、中胆管结扎后,Phb1杂合子小鼠谷胱甘肽合成酶表达下降更明显,肝脏氧化应激更高。
我们已经确定,在大多数人类HCC和CCA中表达下调的PHB1与MAX形成异二聚体以抑制E-box,并正向调节MAT1A,同时抑制c-MYC、MAFG和c-MAF的表达;在小鼠中,PHB1表达降低易导致胆汁淤积性CCA的发生。(《肝脏病学》2017年;65:1249 - 1266)